指南与共识重症综合管理与镇静镇痛消化、代谢与肾脏急症

优化重症后营养治疗:GRIP联盟立场声明与研究框架

Towards optimised nutrition therapy after critical illness: a position statement and research framework by the global research initiative on post-intensive care nutrition (GRIP) consortium.
指南 / 共识 · Crit Care · 2025-10-29
一句话结论GRIP共识将重症后患者定义为ICU停留超过48小时、处于首次ICU转出后恢复期至多1年的成人,并提出10个核心营养研究领域。

全球重症后营养研究倡议(GRIP)召开诊断矩阵会议,邀请国际重症营养专家达成共识。共识将重症后患者定义为任何在ICU停留超过48小时、处于首次ICU转出后恢复期(持续至多1年)的成人,不论住院时长、再入院或出院去向。会议识别出10个核心营养研究领域,涵盖病理生理、表型与个体化营养、时机与递送、摄入监测、干预效果、长期功能与健康相关生活质量、数字工具与远程监测、教育、实施科学及患者家庭参与。GRIP旨在通过填补知识空白、发起针对性研究和支持全球教育,改善重症后营养照护。

要点

  • 重症后患者定义为ICU停留超过48小时、处于首次ICU转出后恢复期至多1年的成人,不论住院时长、再入院或出院去向。
  • GRIP共识识别10个核心营养研究领域,包括病理生理、表型与个体化营养、营养时机与递送、摄入监测与优化等。
  • 营养是重症幸存者恢复的关键组成部分,但ICU后营养管理的循证策略仍不成熟。
  • GRIP愿景是让重症后患者获得个体化、及时、有效的营养照护,以促进恢复、减少并发症并改善长期健康相关生活质量。

适用人群与场景

  • 成人患者,在ICU停留超过48小时,处于首次ICU转出后的恢复期,该恢复期持续至多1年,不论住院时长、再入院或出院去向。

诊断标准与关键阈值

  • 重症后患者定义:任何成人患者,ICU停留超过48小时,处于首次ICU转出后恢复期,恢复期从首次ICU转出后开始持续至多1年,不论住院时长、再入院或出院去向。

研究设计与关键结果

  • GRIP通过诊断矩阵会议达成共识,定义了重症后患者并识别10个核心营养研究领域:(1)重症后恢复的病理生理;(2)表型与个体化营养策略;(3)营养时机与递送;(4)营养摄入监测与优化;(5)营养干预与有效性;(6)长期功能与健康相关生活质量结局;(7)数字工具与远程监测;(8)教育与医疗专业人员参与;(9)实施科学与系统整合;(10)患者与家庭参与。

证据类型、等级与局限

  • 证据类型:国际专家共识(立场声明与研究框架)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,GRIP通过识别知识空白、发起针对性研究项目和支持全球教育,旨在生成可靠证据、促进国际合作并加强临床能力,以改善全球重症后营养照护。

指南或共识出处

  • GRIP(Global Research Initiative on Post-ICU Nutrition)联盟立场声明与研究框架,发表于Critical Care。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: While mortality for critically ill patients has decreased, many survivors face persistent physical, cognitive, and psychological impairments, collectively known as post-intensive care syndrome, which significantly reduce health-related quality of life (HRQoL). Nutrition is a crucial component of recovery, yet evidence-based strategies for post-intensive care unit (ICU) nutritional management remain underdeveloped.

METHODS: The Global Research Initiative on Post-ICU Nutrition (GRIP) was established to address this gap by advancing research, education, and clinical practice in post-ICU nutrition. International experts in the field of critical care nutrition were invited to a diagnostic matrix meeting, to develop a definition of post-ICU patients relevant to GRIP, discuss emerging evidence regarding post-ICU nutritional management, and identify core research domains to guide future research.

RESULTS: The consortium consensus was achieved. A post-ICU patient is defined as any adult patient who has been admitted to an ICU for more than 48 h and is in the post-ICU recovery phase, which begins after the first ICU discharge and continues for up to one year, regardless of hospital length of stay, readmissions, or discharge destination. Ten core nutrition research domains were identified, including: (1) pathophysiology of post-ICU recovery, (2) phenotyping and personalised nutrition strategies, (3) timing and delivery of nutrition, (4) nutritional intake monitoring and optimisation, (5) nutrition interventions and effectiveness, (6) long-term functional and health-related quality of life outcomes, (7) digital tools and remote monitoring, (8) education and healthcare professional engagement, (9) implementation science and system integration, and (10) patient and family involvement.

CONCLUSION: GRIP envisions a future in which patients post-ICU receive personalised, timely, and effective nutritional care to enhance recovery, reduce complications, and improve long-term HRQoL. By identifying knowledge gaps, initiating targeted research projects, and supporting global educational efforts, GRIP aims to generate robust evidence, foster international collaboration, and strengthen clinical capacity to improve global post-ICU nutritional care.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Rosseel Z, Overwater NMP, Aerts M, et al. Towards optimised nutrition therapy after critical illness: a position statement and research framework by the global research initiative on post-intensive care nutrition (GRIP) consortium. Crit Care. 2025. PMID: 41163099. doi:10.1186/s13054-025-05710-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。